Frazier Life Sciences Management’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-386,762
| Closed | -$6.62M | – | 54 |
|
|
2023
Q3 | $6.62M | Hold |
386,762
| – | – | 0.44% | 38 |
|
|
2023
Q2 | $8.98M | Sell |
386,762
-300,000
| -44% | -$6.97M | 0.54% | 33 |
|
|
2023
Q1 | $12.1M | Sell |
686,762
-244,798
| -26% | -$4.32M | 0.88% | 28 |
|
|
2022
Q4 | $25.3M | Buy |
931,560
+125,293
| +16% | +$3.41M | 1.58% | 17 |
|
|
2022
Q3 | $13.9M | Hold |
806,267
| – | – | 1.07% | 23 |
|
|
2022
Q2 | $14.1M | Buy |
806,267
+89,505
| +12% | +$1.56M | 1.33% | 21 |
|
|
2022
Q1 | $12.2M | Buy |
+716,762
| New | +$12.2M | 1.04% | 31 |
|